{"id":"https://openalex.org/W2124336265","doi":"https://doi.org/10.1093/jnci/djs279","title":"Re: Interdisciplinary Critique of Sipuleucel-T as Immunotherapy in Castration-Resistant Prostate Cancer","display_name":"Re: Interdisciplinary Critique of Sipuleucel-T as Immunotherapy in Castration-Resistant Prostate Cancer","publication_year":2012,"publication_date":"2012-07-18","ids":{"openalex":"https://openalex.org/W2124336265","doi":"https://doi.org/10.1093/jnci/djs279","mag":"2124336265","pmid":"https://pubmed.ncbi.nlm.nih.gov/22825556"},"language":"en","primary_location":{"id":"doi:10.1093/jnci/djs279","doi":"https://doi.org/10.1093/jnci/djs279","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jnci/djs279","pdf_url":"https://academic.oup.com/jnci/article-pdf/104/14/1107/7674146/djs279.pdf","source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},"volume":null,"type":"letter","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/jnci/article-pdf/104/14/1107/7674146/djs279.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056766924","display_name":"Philip W. Kantoff","orcid":"https://orcid.org/0000-0001-7275-0597","observed_orcids":["https://orcid.org/0000-0001-7275-0597"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I156802259","display_name":"Eastern Virginia Medical School","ror":"https://ror.org/056hr4255","country_code":"US","type":"education","lineage":["https://openalex.org/I156802259"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I264058686","display_name":"Dendreon (United States)","ror":"https://ror.org/03fm7r592","country_code":"US","type":"company","lineage":["https://openalex.org/I264058686"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"P. W. Kantoff","raw_affiliation_strings":["Correspondence to: Philip W. Kantoff, MD, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA 02215 (","Cancer Care Alliance, School of Medicine, University of Washington, Seattle, WA (CSH);","Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA 02215","Dendreon Corporation, Seattle, WA","Department of Urology, Eastern Virginia Medical School, Norfolk, VA","Genitourinary Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA (PWK); Seattle","Urologic Oncology Program, University of California San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Correspondence to: Philip W. Kantoff, MD, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA 02215 (","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Cancer Care Alliance, School of Medicine, University of Washington, Seattle, WA (CSH);","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA 02215","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dendreon Corporation, Seattle, WA","institution_ids":["https://openalex.org/I264058686"]},{"raw_affiliation_string":"Department of Urology, Eastern Virginia Medical School, Norfolk, VA","institution_ids":["https://openalex.org/I156802259"]},{"raw_affiliation_string":"Genitourinary Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA (PWK); Seattle","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Urologic Oncology Program, University of California San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064961638","display_name":"C. S. Higano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. S. Higano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007578304","display_name":"Eric Jay Small","orcid":"https://orcid.org/0000-0003-3191-6268","observed_orcids":["https://orcid.org/0000-0003-3191-6268"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. J. Small","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013362255","display_name":"James Boyd Whitmore","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. B. Whitmore","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108253612","display_name":"Mark Walter Frohlich","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. W. Frohlich","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5108587864","display_name":"Paul F. Schellhammer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. F. Schellhammer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5056766924"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I156802259","https://openalex.org/I180670191","https://openalex.org/I201448701","https://openalex.org/I264058686","https://openalex.org/I4210117453","https://openalex.org/I4210134579"],"apc_list":{"value":5436,"currency":"USD","value_usd":5436},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":32,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"104","issue":"14","first_page":"1107","last_page":"1109"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0066999997943639755,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sipuleucel-t","display_name":"sipuleucel-T","score":1.0},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9229999780654907},{"id":"https://openalex.org/keywords/age-as-prognostic-factor","display_name":"age as prognostic factor","score":0.8349999785423279},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8939999938011169},{"id":"https://openalex.org/keywords/impact-trial","display_name":"IMPACT trial","score":0.8980000019073486},{"id":"https://openalex.org/keywords/leukapheresis","display_name":"leukapheresis","score":0.8309999704360962},{"id":"https://openalex.org/keywords/immunodepletion","display_name":"immunodepletion","score":0.8769999742507935},{"id":"https://openalex.org/keywords/age-subgroup-analysis","display_name":"age subgroup analysis","score":0.35499998927116394},{"id":"https://openalex.org/keywords/chemotherapy-naive-patients","display_name":"chemotherapy-naive patients","score":0.5929999947547913},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.30799999833106995},{"id":"https://openalex.org/keywords/prostate-cancer-vaccine","display_name":"prostate cancer vaccine","score":0.30399999022483826}],"concepts":[{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.8003517985343933},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6435067057609558},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6277921199798584},{"id":"https://openalex.org/C2779256933","wikidata":"https://www.wikidata.org/wiki/Q58929","display_name":"Castration","level":3,"score":0.5711191892623901},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5491816401481628},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4833628535270691},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.42293867468833923},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.41153091192245483},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3927118182182312},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3281697928905487},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000375","descriptor_name":"Aging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009376","descriptor_name":"Neoplasms, Hormone-Dependent","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014020","descriptor_name":"Tissue Extracts","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017027","descriptor_name":"Protein Tyrosine Phosphatases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019496","descriptor_name":"Cancer Vaccines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1093/jnci/djs279","doi":"https://doi.org/10.1093/jnci/djs279","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jnci/djs279","pdf_url":"https://academic.oup.com/jnci/article-pdf/104/14/1107/7674146/djs279.pdf","source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},{"id":"pmid:22825556","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22825556","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Cancer Institute","raw_type":"Letter"}],"best_oa_location":{"id":"doi:10.1093/jnci/djs279","doi":"https://doi.org/10.1093/jnci/djs279","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jnci/djs279","pdf_url":"https://academic.oup.com/jnci/article-pdf/104/14/1107/7674146/djs279.pdf","source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308970","display_name":"Teva Pharmaceutical Industries","ror":"https://ror.org/01wfv3m53"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320309432","display_name":"F. Hoffmann-La Roche","ror":"https://ror.org/00by1q217"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2124336265.pdf","grobid_xml":"https://content.openalex.org/works/W2124336265.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W1556399965","https://openalex.org/W1971258987","https://openalex.org/W2042094121","https://openalex.org/W2074321172","https://openalex.org/W2092746496","https://openalex.org/W2093316348","https://openalex.org/W2103959341","https://openalex.org/W2123098020","https://openalex.org/W2142200772","https://openalex.org/W2151063703","https://openalex.org/W2161193168","https://openalex.org/W2169258216","https://openalex.org/W2214178759"],"related_works":["https://openalex.org/W2738497209","https://openalex.org/W2589833135","https://openalex.org/W2590130989","https://openalex.org/W2908186789","https://openalex.org/W7095423090","https://openalex.org/W2590282175","https://openalex.org/W7098912256","https://openalex.org/W2161193168","https://openalex.org/W1978485838","https://openalex.org/W7095372283"],"abstract_inverted_index":{"Huber":[0,518,1350,1701],"et":[1,519,1351,1702],"al.":[2,520,1352,1703],"made":[3],"three":[4,377,422,675],"observations":[5],"related":[6,471],"to":[7,15,29,59,93,153,166,251,290,306,406,472,489,506,581,706,784,1034,1112,1357,1436,1513,1536,1587,1650,1879,1891],"the":[8,18,36,45,49,179,191,212,221,235,261,309,318,330,338,343,352,376,388,414,418,426,429,451,473,496,500,525,531,542,558,582,589,596,606,613,644,660,688,745,758,793,799,858,896,899,1006,1013,1073,1086,1121,1127,1186,1224,1227,1334,1341,1360,1363,1374,1401,1424,1442,1466,1477,1491,1497,1500,1551,1578,1581,1593,1616,1627,1632,1654,1658,1661,1691,1720,1880,1885,1892,1897,1907,1911],"phase":[9,264,332,378],"III":[10,265,333,379],"IMPACT":[11,192,328,492,562,645,710,746,1038,1074,1393,1724],"trial":[12,544,802,867,968,1130,1195,1296,1725],"leading":[13],"them":[14],"suggest":[16],"that":[17,413,428,490,595,656,1362,1379,1400,1527,1645],"observed":[19,272],"difference":[20],"in":[21,62,76,85,137,205,273,317,350,391,450,491,534,643,687,709,798,983,1037,1126,1311,1392,1476,1495,1562,1631,1648],"overall":[22,737,1065],"survival":[23,498,550,571,669],"(OS)":[24],"could":[25],"have":[26,56,80,1437,1666],"been":[27],"attributed":[28],"age-dependent":[30],"immunodepletion":[31],"resulting":[32],"from":[33,44,420,443,469,504,541,588,617,699,1027,1580,1774,1790,1818,1838,1859],"leukapheresis":[34,1390,1419,1493,1636],"of":[35,109,123,135,143,158,201,215,223,238,245,260,279,282,298,341,346,372,398,417,431,439,453,464,475,482,495,499,538,551,561,585,608,615,670,702,860,868,929,990,995,1015,1030,1188,1196,1257,1318,1323,1343,1366,1373,1405,1423,1427,1448,1455,1570,1577,1589,1641,1660,1694,1808,1850,1874,1884,1896,1906],"control":[37,156,180,501,532,563,586,598,689,754,794,1082,1122,1501,1552,1582,1604,1612,1633],"arm":[38,599,690,1553,1613,1634],"patients":[39,84,101,224,274,356,392,432,457,540,564,587,616,785,790,822,871,991,1016,1113,1118,1150,1199,1319,1344,1630],"(":[40,66,114,217,357,477,509,513,521,636,679,691,1353,1384,1416,1462,1503,1572],"1":[41,511,522,681,922,953,1250,1281,1354],").":[42,70,118,361,479,517,693,1386,1505,1574],"Evidence":[43],"sipuleucel-T":[46,97,139,197,266,347,380,748,1076,1478,1498,1602,1617,1651,1664],"trials":[47,381,484,701,1029,1618],"and":[48,155,210,292,329,354,365,382,683,697,786,817,835,886,921,944,952,1025,1114,1145,1163,1214,1249,1272,1280,1378,1412,1465,1473,1487,1499,1540,1554,1603,1624,1638,1657,1681,1690,1709,1745,1768,1785,1801,1830,1833,1844,1864,1882,1894,1901,1904,1909],"literature":[50,1449],"refute":[51],"this":[52,243],"alternative":[53],"explanation.":[54],"Studies":[55],"shown":[57,529,1451],"age":[58,126,214,280,340,440,465],"be":[60,91,176,1434,1514,1560],"prognostic":[61,74,88,695,1023],"castration-resistant":[63,77],"prostate":[64,78],"cancer":[65,79,1524],"2":[67,806,826,840,908,939,1134,1154,1168,1236,1267],",":[68,116,359,515],"3":[69,809,843,911,919,928,942,950,1137,1171,1239,1247,1256,1270,1278],"Most":[71],"studies":[72,98,334,423,1479],"investigating":[73],"factors":[75,89,696,1024],"focused":[81],"on":[82,171,323,632,1441,1459,1609],"chemotherapy-treated":[83],"whom":[86,110],"other":[87,1836],"might":[90],"expected":[92,1435,1561],"outweigh":[94],"age.":[95],"The":[96,362,408,447,865,966,979,1193,1294,1307,1387,1575,1611,1663,1697,1723,1867],"exclusively":[99],"enrolled":[100,546,708,1036],"with":[102,242,308,445,485,547,565,603,752,789,820,854,857,878,992,1017,1080,1117,1148,1182,1185,1206,1320,1345,1557,1626],"asymptomatic":[103],"or":[104,295,997,1325],"minimally":[105,650],"symptomatic":[106,651],"disease,":[107],"85%":[108],"were":[111,271,434,459,803,818,902,1131,1146,1230,1480,1547,1555,1596,1704],"chemotherapy":[112,960,1288],"na\u00efve":[113],"4":[115,218,358,514,930,1258],"5":[117,360],"In":[119,257,744,757,895,1072,1085,1223],"a":[120,131,199,239,313,384,535,548,566,621,629,633,667,753,1081,1370,1642,1677,1687,1736,1754],"pooled":[121,373],"analysis":[122,259,371,537,1900],"these":[124,1380,1707],"studies,":[125],"(in":[127],"10-year":[128],"increments)":[129],"was":[130,412,640,750,782,787,863,964,987,999,1003,1078,1110,1115,1191,1292,1315,1327,1331,1619,1646,1726],"statistically":[132],"significant":[133],"predictor":[134],"OS":[136,195,528,560,584,624,735,1063],"both":[138,327,351,821,984,1149,1312,1496,1601],"(hazard":[140],"ratio":[141,449],"[HR]":[142],"death":[144,159,202,283,299,399],"=":[145,151,160,164,284,288,300,304,400,404,573,626,654,715,719,728,732,736,740,1043,1047,1056,1060,1064,1068],"1.28,":[146],"95%":[147,162,286,302,402,1599],"confidence":[148],"interval":[149],"[CI]":[150],"1.12":[152],"1.47)":[154],"(HR":[157,281,297,397],"1.31,":[161],"CI":[163,287,303,403],"1.10":[165],"1.56)":[167],"arms":[168,677,901,986,1229,1314],"(Dendreon":[169,321,1606],"data":[170,254,322,374,419,1608,1665,1899],"file),":[172],"which":[173,639,862,1190],"would":[174,1432,1559],"not":[175,231,641,658,733,1000,1004,1061,1328,1332,1433,1548,1585,1710],"anticipated":[177],"if":[178],"group":[181,533,1583],"had":[182,620],"experienced":[183],"relative":[184],"immunodepletion.":[185],"Among":[186],"63":[187],"subgroups":[188,207],"assessed":[189],"for":[190,255,387,530,612,663,673,927,1009,1255,1337,1359,1600,1615,1679,1719,1739,1757,1877,1914],"study":[193,1655],"report,":[194],"favored":[196],"(ie,":[198],"HR":[200],"<":[203],"1.0)":[204],"all":[206,421,674],"including":[208,1670],"above":[209],"below":[211],"median":[213,339,497,527,559,583,623,668,980,1308,1467,1594],"71":[216],");":[219],"only":[220,1421],"subgroup":[222,246,320,430,452,614,652],"aged":[225],"less":[226,275,435,460],"than":[227,276,394,436,461,553,568,1517,1598],"65":[228,277,293,395,437,462],"years":[229,278,294,396,438,463],"did":[230,657,1584],"favor":[232],"sipuleucel-T.":[233,446],"Given":[234,1399],"high":[236],"probability":[237],"false-positive":[240],"result":[241],"number":[244,1426],"analyses,":[247],"it":[248,578],"is":[249,348,1407,1806],"important":[250],"seek":[252],"additional":[253],"consistency.":[256],"an":[258,370,890,1218,1563,1567,1671],"first":[262],"two":[263],"trials,":[267],"positive":[268],"treatment":[269,315,344,389,444,602,676,900,985,1228,1313],"effects":[270,1454],"0.57,":[285],"0.27":[289],"1.21)":[291],"older":[296,355],"0.69,":[301],"0.49":[305],"0.98),":[307],"trend":[310],"actually":[311,1511],"favoring":[312],"greater":[314,552,1597],"effect":[316,345,390,1440],"younger":[319,353,393],"file).":[324,1610],"Furthermore,":[325,605,1506],"when":[326],"earlier":[331],"are":[335,1848],"dichotomized":[336],"at":[337,575,1484],"71,":[342],"consistent":[349,1556],"US":[363],"Food":[364],"Drug":[366],"Administration":[367],"(FDA)":[368],"performed":[369],"across":[375],"obtained":[383],"favorable":[385],"estimate":[386],"0.92,":[401],"0.62":[405],"1.37).":[407],"FDA":[409,1672,1675],"reviewers\u2019":[410],"conclusion":[411],"\u201c\u2026":[415],"analyses":[416],"\u2026":[424],"support":[425,1718],"hypothesis":[427],"who":[433,458,545,619,791,823,837,872,880,888,1119,1151,1165,1200,1208,1216],"also":[441],"benefit":[442],"hazard":[448],"Study":[454],"D9902B":[455],"[IMPACT]":[456],"most":[466],"likely":[467],"resulted":[468],"chance,":[470],"multiplicity":[474],"comparisons\u2026\u201d":[476],"6":[478],"A":[480,647],"review":[481,1693],"recent":[483],"patient":[486,703,1031],"populations":[487,704,1032,1381],"comparable":[488,705,1033],"demonstrates":[493],"consistency":[494],"arms,":[502],"ranging":[503],"16.6":[505],"21.5":[507],"months":[508,672,685],"Table":[510,680],")":[512,523,682,1355],"7":[516,996,1324],"cited":[524],"27.1-month":[526],"subset":[536,591],"264":[539],"GVAX":[543,590,597],"Halabi-predicted":[549,570],"18":[554],"months.":[555],"We":[556],"calculated":[557],"more":[567],"18-month":[569],"(n":[572,625,653],"114);":[574],"26.7":[576],"months,":[577],"compares":[579],"favorably":[580],"analysis,":[592],"particularly":[593],"given":[594,1711],"involved":[600],"active":[601],"docetaxel.":[604],"definition":[607],"\u201cminimally":[609],"symptomatic\u201d":[610],"used":[611],"TAX327":[618,649],"25.6-month":[622],"110)":[627],"included":[628,642],"minimal":[630],"score":[631,982,994,1310,1322],"quality-of-life":[634,661],"questionnaire":[635],"8":[637,765,1093],"),":[638,1418,1464],"definition.":[646],"larger":[648],"550)":[655],"include":[659],"criterion":[662],"defining":[664],"symptomatology":[665],"revealed":[666],"21.3":[671],"combined":[678],"19.8":[684],"specifically":[686],"9":[692,773,1101,1397],"Key":[694,1022],"outcomes":[698,1026],"clinical":[700,866,1028,1194,1541],"those":[707,836,879,887,1035,1164,1207,1215],"(4,7)*":[711,1039],"*":[712,1040],"Alk":[713,1041],"Phos":[714,1042],"alkaline":[716,1044],"phosphatase;":[717,1045],"ECOG":[718,1002,1010,1046,1330,1338],"Eastern":[720,1048],"Cooperative":[721,1049],"Oncology":[722,1050],"Group":[723,1051],"performance":[724,1052],"status":[725,1053],"scale;":[726,1054],"LDH":[727,1055],"lactate":[729,1057],"dehydrogenase;":[730,1058],"NR":[731,1059],"reported;":[734,1005,1062,1333],"survival;":[738,1066],"PSA":[739,1067],"prostate-specific":[741,1069],"antigen.":[742,1070],"\u2020":[743,1071],"trial,":[747,760,898,1075,1088,1226],"(S)":[749,1077],"compared":[751,788,819,870,969,1079,1116,1147,1198,1297],"intervention":[755,795,1083,1123,1614],"(C).":[756,796,1084,1124],"prostvac":[759,1087],"recombinant":[761,769,776,1089,1097,1104],"vaccinia":[762,1090],"vector-PSA-TRICOM":[763,1091],"(2\u00d710":[764,1092],"pfu)":[766,774,1094,1102],"followed":[767,1095],"by":[768,1096,1522,1700,1728],"Fowlpox-PSA-TRICOM":[770,1098],"boost":[771,1099],"(1\u00d710":[772,1100],"+":[775,811,829,845,906,913,937,1103,1139,1157,1173,1234,1241,1265],"granulocyte-macrophage":[777,1105],"colony-stimulating":[778,1106],"factor":[779,1107],"adjuvant":[780,1108],"(PV)":[781,1109],"administered":[783,804,1111,1132],"received":[792,824,838,881,889,1120,1152,1166,1209,1217,1716,1771,1788,1816,1835,1857],"Patients":[797,1125],"Tax":[800,1128],"327":[801,1129],"75mg/m":[805,938,1133,1266],"docetaxel":[807,827,909,925,940,956,1135,1155,1237,1253,1268,1284],"every":[808,842,910,941,1136,1170,1238,1269],"weeks":[810,844,912,931,943,1138,1172,1240,1259,1271,1489],"5mg":[812,830,846,1140,1158,1174],"prednisone":[813,831,847,934,1141,1159,1175,1262],"twice":[814,832,848,935,1142,1160,1176,1263],"daily":[815,833,849,876,884,893,905,936,972,977,1143,1161,1177,1204,1212,1221,1233,1264,1300,1305],"(D3P)":[816,1144],"30mg/m":[825,1153],"weekly":[828,1156],"(D1P)":[834,1162],"12mg/m":[839,1167],"mitoxantrone":[841,1169],"(MP).":[850,1178],"No":[851,1179,1713],"previous":[852,1180],"therapy":[853,1181],"chemotoxic":[855,1183],"agents":[856,1184],"exeption":[859,1187],"estramustine,":[861,1189],"allowed.":[864,965,1192,1293],"zibotentan":[869,875,883,1197,1203,1211],"recieved":[873,1201],"15mg":[874,1202],"(Z15)":[877,1205],"10mg":[882,970,1210,1298],"(Z10)":[885,1213],"oral":[891,915,946,975,1219,1243,1274,1303],"placebo":[892,976,1220,1304],"(P).":[894,978,1222,1306],"ASCENT-2":[897,1225],"high-dose":[903,1231],"calcitriol":[904,1232],"36mg/m":[907,1235],"8mg":[914,945,1242,1273],"dexamethasone":[916,947,1244,1275],"12":[917,948,1245,1276,1414],"hours,":[918,920,949,951,1246,1248,1277,1279],"hour":[923,954,1251,1282],"before":[924,955,1252,1283,1530],"infusion":[926,957,1254,1285,1588,1640],"(CD1)":[932,1260],"vs":[933,974,1261,1302],"(PD3).":[958,1286],"Prior":[959,1287],"(only":[961,1289],"estramustine":[962,1290],"monotherapy)":[963,1291],"atrasentan":[967,971,1295,1299],"(A)":[973,1301],"Gleason":[981,993,1309,1321],"7;":[988,1316],"percentage":[989,1014,1317,1342,1431],"lower":[998,1326],"reported.":[1001,1329],"value":[1007,1335],"listed":[1008,1336],"0\u20131":[1011,1339],"represents":[1012,1340,1369],"Karnofsky":[1018,1346],"Performance":[1019,1347],"Status":[1020,1348],"100\u201380.":[1021,1349],"failed":[1356],"account":[1358],"fact":[1361],"intravascular":[1364],"pool":[1365,1377,1404],"mononuclear":[1367],"cells":[1368,1415,1507,1579],"small":[1371,1430],"fraction":[1372],"total":[1375,1402,1425],"body":[1376,1403,1447],"rapidly":[1382],"reequilibrate":[1383],"10":[1385],"1.5\u20132.0":[1388],"volume":[1389],"procedure":[1391,1494],"removed":[1394,1420],"approximately":[1395],"7\u00d710":[1396],"lymphocytes.":[1398,1428],"lymphocytes":[1406],"estimated":[1408],"between":[1409],"5\u00d710":[1410],"11":[1411],"6\u00d710":[1413],"11\u201313":[1417],"0.1%\u20131.4%":[1422],"This":[1429],"any":[1438],"substantive":[1439],"lymphocyte":[1443],"repertoire.":[1444],"An":[1445],"extensive":[1446],"has":[1450,1715,1751,1815,1834,1856],"no":[1452],"detrimental":[1453],"repeated":[1456],"apheresis":[1457],"procedures":[1458,1637],"healthy":[1460],"donors":[1461],"14":[1463],"white":[1468],"blood":[1469],"cell,":[1470],"neutrophil,":[1471],"lymphocyte,":[1472],"monocyte":[1474],"counts":[1475],"within":[1481],"normal":[1482],"ranges":[1483],"2,":[1485],"10,":[1486],"22":[1488],"following":[1490],"third":[1492],"groups":[1502,1605],"15":[1504,1573],"undergoing":[1508],"homeostatic":[1509],"proliferation":[1510],"tend":[1512],"more,":[1515],"rather":[1516],"less,":[1518],"immunoreactive,":[1519],"as":[1520,1735,1753],"evidenced":[1521],"multiple":[1523,1695],"immunotherapy":[1525],"protocols":[1526],"induce":[1528],"lymphopenia":[1529],"immunization":[1531],"and/or":[1532],"adoptive":[1533],"T-cell":[1534],"transfer":[1535],"augment":[1537],"immune":[1538],"activation":[1539],"efficacy.":[1542],"Finally,":[1543],"infection-related":[1544],"adverse":[1545],"events":[1546],"increased":[1549],"among":[1550],"what":[1558],"elderly":[1564],"population":[1565],"over":[1566],"extended":[1568],"period":[1569],"follow-up":[1571],"storage":[1576],"lead":[1586],"dead":[1590],"cells,":[1591],"because":[1592],"viabilities":[1595],"unpublished":[1607],"chosen":[1620],"after":[1621],"careful":[1622],"consideration":[1623],"discussion":[1625],"FDA.":[1628],"Having":[1629],"undergo":[1635],"subsequent":[1639],"cellular":[1643],"product":[1644],"identical":[1647],"appearance":[1649],"substantially":[1652],"strengthened":[1653],"design":[1656,1895],"interpretability":[1659],"results.":[1662],"undergone":[1667],"rigorous":[1668],"review,":[1669,1676],"advisory":[1673],"committee,":[1674],"Center":[1678],"Medicare":[1680],"Medicaid":[1682],"Services":[1683],"national":[1684],"coverage":[1685],"determination,":[1686],"Technology":[1688],"Assessment,":[1689],"peer":[1692],"publications.":[1696],"issues":[1698],"raised":[1699],"considered":[1705],"during":[1706],"reviews":[1708],"credence.":[1712],"author":[1714],"financial":[1717],"submitted":[1721,1886],"work.":[1722,1887],"funded":[1727],"Dendreon":[1729,1746,1769,1786,1802,1831,1839,1851,1865,1875],"Corp.":[1730,1747,1840,1852,1866],"P.":[1731,1853],"W.":[1732,1846],"Kantoff":[1733],"served":[1734,1752],"paid":[1737,1755],"consultant":[1738,1756],"Bellicum,":[1740],"BN-IT,":[1741],"Janssen,":[1742],"Bayer,":[1743,1761,1776,1794,1863],"Sanofi-Aventis,":[1744,1766,1783,1799],"C.":[1748,1871],"S.":[1749],"Higano":[1750],"Amgen,":[1758,1775,1791,1860],"Astra":[1759,1792,1861],"Zeneca,":[1760,1793,1862],"Bristol-Myers":[1762,1795],"Squibb,":[1763,1796],"Medivation,":[1764,1781,1797],"Millennium,":[1765,1782,1798,1829],"Teva,":[1767,1784,1800],"Corp;":[1770,1787,1803],"research":[1772],"funding":[1773],"Cell":[1777,1809],"Genesys,":[1778],"Cougar,":[1779],"Imclone,":[1780],"honoraria":[1789,1817,1858],"her":[1804],"spouse":[1805],"cofounder":[1807],"Therapeutics,":[1810],"Inc.":[1811],"E.":[1812],"J.":[1813,1841],"Small":[1814],"Celgene":[1819],"Corp,":[1820],"F":[1821],"Hoffman-La":[1822],"Roche":[1823],"Ltd,":[1824],"J&J":[1825],"Pharma":[1826],"Serv,":[1827],"LLC,":[1828],"Corp":[1832,1876],"remuneration":[1837],"B.":[1842],"Whitmore":[1843],"M.":[1845],"Frohlich":[1847],"employees":[1849],"F.":[1854],"Schellhammer":[1855],"authors":[1868,1889],"thank":[1869],"Johnathan":[1870],"Maher,":[1872],"PhD,":[1873],"contributing":[1878],"writing":[1881,1903],"editing":[1883,1905],"All":[1888],"contributed":[1890],"conception":[1893],"manuscript,":[1898,1908],"interpretation,":[1902],"approved":[1910],"final":[1912],"version":[1913],"submission.":[1915]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}